In the remaining 455 of 575 samples in the Beat-AML cohort, SLAMF6 expression correlated with improved survival but all groups displayed 5-year survival rates of less than 50% (Extended Data Fig. 3b, c). The gene discussed is SLAMF6; the disease is acute myeloid leukemia.